Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: Fierce 15 nominations are now open! We're looking for the best and brightest in biotech.
CSL Behring
Biotech
CSL's largest ph. 3 trial ends in failure for heart attack drug
CSL’s largest trial has ended in failure, as the pharma revealed that its cholesterol efflux enhancer was unable to reduce the risk of heart attacks.
James Waldron
Feb 12, 2024 5:21am
Roche's executive dominoes continue to tip—Chutes & Ladders
Dec 16, 2022 9:30am
CSL Behring unveils its largest R&D site, slated to open in 2022
Sep 14, 2022 10:45am
FDA accepts CSL Behring’s gene therapy for speedy review
May 24, 2022 10:59am